| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
James Treco is Director at TNXP. James Treco's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1K at current prices.
Net of sales, the TNXP filings show accumulation of 10,250 shares.
James Treco has 14 Form 4 filings on record from February 2019 to May 2026, all as Director at Tonix Pharmaceuticals (TNXP), 2019–2026.
The 14 reported transactions were 10 option or other derivative awards, 3 open-market purchases and 1 other transaction.
Counted by filing, the open-market trades come to 3 purchases worth about $19K and no sales.
The largest open-market purchase was 250 shares of TNXP at an average $36.00 on August 20, 2025, about $9K. Twelve months later TNXP was down 66%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Director | Buy | 250 | $36.00 | $9,000.00 | New | -54.8% | -65.6% | |
| Aug 31, 2020 | TNXP Tonix Pharmaceuticals Holding Corp. | Director | Buy | 5,500 | $0.89 | $4,895.00 | +122.2% | - | - | |
| Aug 14, 2020 | TNXP Tonix Pharmaceuticals Holding Corp. | Director | Buy | 4,500 | $1.06 | $4,770.00 | New | - | - |